7.600EUR-5.00%Mkt Cap: 32.23M EURP/E: InfinityLast update: 2026-05-14
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic a…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)Infinity
P/E (Forward)-62.08
PEG—
P/B0.84
P/S—
EV/EBITDA—
EV/Revenue—
EPS (TTM)0.00
EPS (Forward)-0.12
Cash Flow & Leverage
FCF Yield-2.83%
FCF Margin—
Operating CF-1.30M EUR
CapEx (TTM)—
Net Debt/EBITDA—
Net Debt-12.90M EUR
Technical
SMA 507.813 (-2.7%)
SMA 2007.963 (-4.6%)
Beta0.41
S&P 52W Chg24.23%
Avg Vol (30d)246
Avg Vol (10d)608
Technical Indicators
RSI (14)29.8
MACD0.0131
MACD Signal0.0458
MACD Hist.-0.0327
BB Upper8.263 EUR
BB Middle7.987 EUR
BB Lower7.712 EUR
BB Width6.89%
ATR (14)0.0618 EUR
Vol Ratio (20d)147.43x
52W Range
7.00026% of range9.300
52W High9.300 EUR
52W Low7.000 EUR
Profitability
Gross Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
Oper. Margin0.00%
ROE0.00%
ROA0.00%
Revenue Growth—
Earnings Growth—
Balance Sheet
Debt/Equity0.00
Current Ratio16.13
Quick Ratio16.13
Book Value/Sh8.904 EUR
Cash/Share2.976 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.4.33M
Float902.92K
Insiders29.96%
Institutions35.00%
Analyst Consensus
Rating—
Target (Mean)15.50 EUR
Target Range15.50 EUR – 15.50 EUR
# Analysts1
Company
Market Cap32.23M EUR
Enterprise Value19.40M EUR
Revenue (TTM)—
Gross Profit—
Net Income (TTM)0 EUR
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
Last Price7.600 EUR
CountryIE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—